Technical Analysis for WAVE - Waverly Pharma Inc.

Grade Last Price % Change Price Change
F 0.020 0.00% 0.000
WAVE closed up 33.33 percent on Wednesday, July 17, 2024, on 16 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Aug 16
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 33.33%
Narrow Range Bar Range Contraction 33.33%
Wide Bands Range Expansion 33.33%
Oversold Stochastic Weakness 33.33%
Stochastic Buy Signal Bullish 33.33%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High 10 days ago
Rose Above 10 DMA 10 days ago
Up 5% 10 days ago
Up 3% 10 days ago
Up 2% 10 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Waverley Pharma Inc is a Canada-based company engaged in Biotechnology & Medical Research sector.The Company is focused on developing and commercializing Safe and Effective Small Molecules for Treatment of Cancer. Waverley Pharma is working in collaboration with a Indian conglomerate based in Mumbai to develop products for the treatment of cancer. Two of the lead products under developments are: WAV-101: WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications; WAV-102 is also an injectable generic chemotherapy drug developed for the treatment of multiple myeloma and other indications. The Company has signed an agreement with Omgene Life Sciences for the development of another generic anti-cancer product WAV-103.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Occupational Safety And Health Medicine Pharma Labor Drug Biotechnology Science Cancer Life Sciences Therapy Collaboration Oncology Drug Development Lung Cancer Treatment Of Cancer Chemotherapy Non Small Cell Lung Cancer Multiple Myeloma Treatment Of Non Small Cell Lung Cancer

Is WAVE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.14
52 Week Low 0.015
Average Volume 18,230
200-Day Moving Average 0.054
50-Day Moving Average 0.024
20-Day Moving Average 0.021
10-Day Moving Average 0.020
Average True Range 0.006
RSI (14) 49.75
ADX 10.27
+DI 33.484
-DI 22.059
Chandelier Exit (Long, 3 ATRs) 0.016
Chandelier Exit (Short, 3 ATRs) 0.034
Upper Bollinger Bands 0.033
Lower Bollinger Band 0.009
Percent B (%b) 0.46
BandWidth 111.429
MACD Line -0.002
MACD Signal Line -0.002
MACD Histogram -0.0006
Fundamentals Value
Market Cap 1.08 Million
Num Shares 54 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -1.25
Price-to-Sales 6.91
Price-to-Book 3.16
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.020
Resistance 3 (R3) 0.020 0.020 0.020
Resistance 2 (R2) 0.020 0.020 0.020 0.020
Resistance 1 (R1) 0.020 0.020 0.020 0.020 0.020
Pivot Point 0.020 0.020 0.020 0.020 0.020
Support 1 (S1) 0.020 0.020 0.020 0.020 0.020
Support 2 (S2) 0.020 0.020 0.020 0.020
Support 3 (S3) 0.020 0.020 0.020
Support 4 (S4) 0.020